Nail Detachment Quadruples in GLP-1 Users, Cross-Sectional Data Show

Researchers surveyed 575 GLP-1 users and 1,329 controls across four countries using patient-reported questionnaires. Nail disorders overall affected 66% of users versus 53% of controls, with discoloration rising from 17% to 46%. Associations for detachment and discoloration persisted at two- to three-fold after adjustment for weight loss, dermatologic conditions, and nutritional status, indicating factors beyond caloric deficit alone.

Companion data from the same cohort showed hair loss and scalp inflammation also elevated, with post-treatment shedding twice as common and scalp redness three times more frequent among users. These patterns suggest an inflammatory component possibly tied to GLP-1 effects on keratinocyte turnover or micronutrient handling rather than weight loss per se.

The studies remain observational and rely on self-report, precluding causal inference. Half of users noted nail issues predating therapy, and residual confounding by unmeasured nutritional or metabolic shifts cannot be excluded. Next steps require prospective cohorts tracking onset timing, objective nail metrics, and dose-response relationships before changes in monitoring guidelines.